Last reviewed · How we verify

NCT05971316

Effectiveness of a Warm-Up With Foam Roller in Professional Basketball Players

Completed NA Last updated 2 August 2023
What this trial tests

NA trial testing Foam Roller in Athletics Injury in 22 participants. Completed in 15 March 2023.

Timeline
20 September 2022
Primary endpoint
2 February 2023
15 March 2023

Quick facts

Lead sponsorUniversidad de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment22
Start date20 September 2022
Primary completion2 February 2023
Estimated completion15 March 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Murcia — full company profile →

Who can join

Adults 18 to 30, any sex, with Athletics Injury or Sports Physical Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to analyze the effectiveness of a foam roller warm-up on sports performance in professional basketball players.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness of a Foam Roller Warm-Up in Professional Basketball Players: A Randomized Controlled Trial.
    Casado D, Nacher I, Pardo J, Reina J. · · 2025 · cited 3× · PMID 39758693 · DOI 10.26603/001c.127266
  2. Association Between Balance and Hip Muscle Strength in Inline Skaters.
    Sánchez Torres L, Moltó IN, Navia JA, Reina Abellán J. · · 2025 · PMID 40981031 · DOI 10.3390/jfmk10030331

Verify or expand the search:

Other trials of Foam Roller

Trials testing the same drug.

Other Universidad de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05971316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing